Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 298

1.

Tumor Cells Develop Defined Cellular Phenotypes After 3D-Bioprinting in Different Bioinks.

Schmidt SK, Schmid R, Arkudas A, Kengelbach-Weigand A, Bosserhoff AK.

Cells. 2019 Oct 22;8(10). pii: E1295. doi: 10.3390/cells8101295.

2.

Loss of CYLD accelerates melanoma development and progression in the Tg(Grm1) melanoma mouse model.

de Jel MM, Schott M, Lamm S, Neuhuber W, Kuphal S, Bosserhoff AK.

Oncogenesis. 2019 Oct 7;8(10):56. doi: 10.1038/s41389-019-0169-4.

3.

C-Jun drives melanoma progression in PTEN wild type melanoma cells.

Kappelmann-Fenzl M, Gebhard C, Matthies AO, Kuphal S, Rehli M, Bosserhoff AK.

Cell Death Dis. 2019 Aug 5;10(8):584. doi: 10.1038/s41419-019-1821-9.

4.

Role of melanoma inhibitory activity in melanocyte senescence.

Feuerer L, Lamm S, Henz I, Kappelmann-Fenzl M, Haferkamp S, Meierjohann S, Hellerbrand C, Kuphal S, Bosserhoff AK.

Pigment Cell Melanoma Res. 2019 Nov;32(6):777-791. doi: 10.1111/pcmr.12801. Epub 2019 Jun 21.

PMID:
31172672
5.

Acidification is an Essential Process of Cold Atmospheric Plasma and Promotes the Anti-Cancer Effect on Malignant Melanoma Cells.

Schneider C, Gebhardt L, Arndt S, Karrer S, Zimmermann JL, Fischer MJM, Bosserhoff AK.

Cancers (Basel). 2019 May 14;11(5). pii: E671. doi: 10.3390/cancers11050671.

6.

Bone Morphogenetic Protein-6 Inhibits Fibrogenesis in Scleroderma Offering Treatment Options for Fibrotic Skin Disease.

Arndt S, Karrer S, Hellerbrand C, Bosserhoff AK.

J Invest Dermatol. 2019 Sep;139(9):1914-1924.e6. doi: 10.1016/j.jid.2019.02.020. Epub 2019 Mar 13.

PMID:
30878675
7.

Phototherapy-induced elevation of serum level of melanoma inhibitory activity.

Datz E, Zeman F, Koller M, Szeimies RM, Berneburg M, Landthaler M, Bosserhoff AK, Karrer S.

Photodermatol Photoimmunol Photomed. 2019 Jul;35(4):255-260. doi: 10.1111/phpp.12461. Epub 2019 Mar 25.

PMID:
30815924
8.

Neuroblastoma RAS Viral Oncogene Homolog (NRAS) Is a Novel Prognostic Marker and Contributes to Sorafenib Resistance in Hepatocellular Carcinoma.

Dietrich P, Gaza A, Wormser L, Fritz V, Hellerbrand C, Bosserhoff AK.

Neoplasia. 2019 Mar;21(3):257-268. doi: 10.1016/j.neo.2018.11.011. Epub 2019 Jan 25.

9.

The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion.

Graf SA, Heppt MV, Wessely A, Krebs S, Kammerbauer C, Hornig E, Strieder A, Blum H, Bosserhoff AK, Berking C.

Pigment Cell Melanoma Res. 2019 May;32(3):424-434. doi: 10.1111/pcmr.12760. Epub 2018 Dec 21.

PMID:
30506895
10.

Encapsulation of Rat Bone Marrow Derived Mesenchymal Stem Cells in Alginate Dialdehyde/Gelatin Microbeads with and without Nanoscaled Bioactive Glass for In Vivo Bone Tissue Engineering.

Rottensteiner-Brandl U, Detsch R, Sarker B, Lingens L, Köhn K, Kneser U, Bosserhoff AK, Horch RE, Boccaccini AR, Arkudas A.

Materials (Basel). 2018 Oct 1;11(10). pii: E1880. doi: 10.3390/ma11101880.

11.

BMP6-induced modulation of the tumor micro-milieu.

Stieglitz D, Lamm S, Braig S, Feuerer L, Kuphal S, Dietrich P, Arndt S, Echtenacher B, Hellerbrand C, Karrer S, Bosserhoff AK.

Oncogene. 2019 Jan;38(5):609-621. doi: 10.1038/s41388-018-0475-x. Epub 2018 Aug 31.

PMID:
30171260
12.

Cold atmospheric plasma causes a calcium influx in melanoma cells triggering CAP-induced senescence.

Schneider C, Gebhardt L, Arndt S, Karrer S, Zimmermann JL, Fischer MJM, Bosserhoff AK.

Sci Rep. 2018 Jul 3;8(1):10048. doi: 10.1038/s41598-018-28443-5.

13.

Cold atmospheric plasma treatment inhibits growth in colorectal cancer cells.

Schneider C, Arndt S, Zimmermann JL, Li Y, Karrer S, Bosserhoff AK.

Biol Chem. 2018 Dec 19;400(1):111-122. doi: 10.1515/hsz-2018-0193.

PMID:
29908123
14.

The importance of melanoma inhibitory activity gene family in the tumor progression of oral cancer.

Sasahira T, Bosserhoff AK, Kirita T.

Pathol Int. 2018 May;68(5):278-286. doi: 10.1111/pin.12672. Epub 2018 Apr 14. Review.

PMID:
29655307
15.

Selenium-binding protein 1 is down-regulated in malignant melanoma.

Schott M, de Jel MM, Engelmann JC, Renner P, Geissler EK, Bosserhoff AK, Kuphal S.

Oncotarget. 2018 Jan 2;9(12):10445-10456. doi: 10.18632/oncotarget.23853. eCollection 2018 Feb 13.

16.

MicroRNA-622 is a novel mediator of tumorigenicity in melanoma by targeting Kirsten rat sarcoma.

Dietrich P, Kuphal S, Spruss T, Hellerbrand C, Bosserhoff AK.

Pigment Cell Melanoma Res. 2018 Sep;31(5):614-629. doi: 10.1111/pcmr.12698. Epub 2018 Mar 25.

PMID:
29495114
17.

Combined effects of PLK1 and RAS in hepatocellular carcinoma reveal rigosertib as promising novel therapeutic "dual-hit" option.

Dietrich P, Freese K, Mahli A, Thasler WE, Hellerbrand C, Bosserhoff AK.

Oncotarget. 2017 Dec 11;9(3):3605-3618. doi: 10.18632/oncotarget.23188. eCollection 2018 Jan 9.

18.

UVB radiation represses CYLD expression in melanocytes.

Kuphal S, Schneider N, Massoumi R, Hellerbrand C, Bosserhoff AK.

Oncol Lett. 2017 Dec;14(6):7262-7268. doi: 10.3892/ol.2017.7120. Epub 2017 Oct 3.

19.

Wild type Kirsten rat sarcoma is a novel microRNA-622-regulated therapeutic target for hepatocellular carcinoma and contributes to sorafenib resistance.

Dietrich P, Koch A, Fritz V, Hartmann A, Bosserhoff AK, Hellerbrand C.

Gut. 2018 Jul;67(7):1328-1341. doi: 10.1136/gutjnl-2017-315402. Epub 2017 Dec 23.

PMID:
29275358
20.

Cold atmospheric plasma (CAP) activates angiogenesis-related molecules in skin keratinocytes, fibroblasts and endothelial cells and improves wound angiogenesis in an autocrine and paracrine mode.

Arndt S, Unger P, Berneburg M, Bosserhoff AK, Karrer S.

J Dermatol Sci. 2018 Feb;89(2):181-190. doi: 10.1016/j.jdermsci.2017.11.008. Epub 2017 Nov 26.

PMID:
29191392

Supplemental Content

Loading ...
Support Center